Antiplatelet treatment in patients with diabetes mellitus: is there a difference between aspirin, clopidogrel and prasugrel

Trial Profile

Antiplatelet treatment in patients with diabetes mellitus: is there a difference between aspirin, clopidogrel and prasugrel

Completed
Phase of Trial: Phase II/III

Latest Information Update: 29 Jun 2015

At a glance

  • Drugs Prasugrel (Primary) ; Aspirin; Clopidogrel
  • Indications Cardiovascular disorders; Thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Oct 2013 Accrual to date is 128% according to United Kingdom Clinical Research Network.
    • 10 Oct 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 05 Jun 2013 Accrual to date is 128% according to United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top